Description

Quantitative detection of antibodies to hepatitis B surface antigen (anti‑HBs) in human serum or plasma to aid in determining immune status following vaccination or infection (Atellica IM). Analyzer: Atellica IM; Method: Chemiluminescent immunoassay; Sample types: Serum/Plasma (per IFU); Storage: 2–8°C; Reagents: Ready-to-use; Calibration/Controls per IFU; Note: Verify kit size/tests per regional IFU.